Peptide record

TPDB93338

Cyclo (His-Pro) Blood-Brain Barrier modified_plain modified
5 source-reported length (unverified)
Basic Information
TPDB93338
Cyclo (His-Pro)
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A modified blood-brain barrier peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 5 (unverified).
Modified, details unspecified
Sequence
c(HP)

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
5 source-reported length (unverified)
Linear Cyclic Activity
Cyclo (His-Pro) Activity
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3 Activity
Evidence Records 5 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
-0.09

Assay & Model

Shake Flask
Log P

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.000179 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
0.0239 ml/g

Assay & Model

Initial disrobution volume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
25.6 min

Assay & Model

half life, brain

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.0118 min-1

Assay & Model

Brain elimination rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Additional Detail Fields 1 fields
Intravenous